QTc intervals and electrolytes in the patients with torsades de pointes
Days of treatment . | QT . | HR . | QTc (msec) . | Cumulative dose of arsenic (mg) . | K . | Mg . |
---|---|---|---|---|---|---|
Patient 1 | ||||||
Day 36 | 0.29 | 120 | 0.41 | 720 | 3.5 | — |
Day 38 | 0.24 | 166 | 0.40 | 760 | 2.9 | 3.6 |
Day 41 | 0.28 | 150 | 0.45 | 820 | 3.9 | 2.0 |
Day 42 (TDP) | 0.28 | 146 | 0.44 | 840 | 3.3 | 1.7 |
Patient 2 | ||||||
Pretreatment | 0.26 | 152 | 0.42 | 0 | 4.0 | 1.8 |
Day 7 | 0.32 | 112 | 0.42 | 140 | 3.8 | 2.1 |
Day 12 | 0.34 | 105 | 0.45 | 240 | 3.1 | — |
Day 15 | 0.28 | 160 | 0.46 | 300 | 3.1 | — |
Day 16 (TDP) | 0.32 | 136 | 0.48 | 320 | 3.1 | 1.5 |
Patient 3 | ||||||
Pretreatment | 0.32 | 112 | 0.435 | 0 | 2.7 | 1.2 |
Day 3 | 0.32 | 126 | 0.43 | 20 | 2.8 | 1.4 |
Day 8 | 0.36 | 110 | 0.48 | 70 | 3.0 | 1.6 |
Day 9 | 0.3 | 164 | 0.5 | 70* | 3.0 | 1.4 |
Day 10 | 0.32 | 146 | 0.48 | 70 | 3.5 | 2.1 |
Day 12 (TDP) | 0.3 | 136 | 0.45 | 70 | 4.0 | 2.5 |
Days of treatment . | QT . | HR . | QTc (msec) . | Cumulative dose of arsenic (mg) . | K . | Mg . |
---|---|---|---|---|---|---|
Patient 1 | ||||||
Day 36 | 0.29 | 120 | 0.41 | 720 | 3.5 | — |
Day 38 | 0.24 | 166 | 0.40 | 760 | 2.9 | 3.6 |
Day 41 | 0.28 | 150 | 0.45 | 820 | 3.9 | 2.0 |
Day 42 (TDP) | 0.28 | 146 | 0.44 | 840 | 3.3 | 1.7 |
Patient 2 | ||||||
Pretreatment | 0.26 | 152 | 0.42 | 0 | 4.0 | 1.8 |
Day 7 | 0.32 | 112 | 0.42 | 140 | 3.8 | 2.1 |
Day 12 | 0.34 | 105 | 0.45 | 240 | 3.1 | — |
Day 15 | 0.28 | 160 | 0.46 | 300 | 3.1 | — |
Day 16 (TDP) | 0.32 | 136 | 0.48 | 320 | 3.1 | 1.5 |
Patient 3 | ||||||
Pretreatment | 0.32 | 112 | 0.435 | 0 | 2.7 | 1.2 |
Day 3 | 0.32 | 126 | 0.43 | 20 | 2.8 | 1.4 |
Day 8 | 0.36 | 110 | 0.48 | 70 | 3.0 | 1.6 |
Day 9 | 0.3 | 164 | 0.5 | 70* | 3.0 | 1.4 |
Day 10 | 0.32 | 146 | 0.48 | 70 | 3.5 | 2.1 |
Day 12 (TDP) | 0.3 | 136 | 0.45 | 70 | 4.0 | 2.5 |
Arsenic discontinued, not restarted; HR, heart rate.
Normal ranges: K, 3.5 to 5.0 mEq/L; Mg, 1.4 to 2.6 mg/dL.
Normal QTc interval, ≤ 0.44 seconds.